The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of a plasmid DNA–based immunotherapy encoding the hTERT, PSMA, and WT1 (INO-5401) +/- IL12 (INO-9012) followed by electroporation in cancer patients and healthy individuals with BRCA1/2 mutations.
 
Susan Domchek
Honoraria - Intellia Therapeutics
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst)
 
Alexandra Torres
No Relationships to Disclose
 
Megan Aaron
No Relationships to Disclose
 
Joann Miller
No Relationships to Disclose
 
Philip Seger
No Relationships to Disclose
 
Hayley Knollman
No Relationships to Disclose
 
Kim Reiss
Honoraria - MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Carisma Therapeutics; Foundation Medicine; Guardant Health; Merus NV; MOMA Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology; GlaxoSmithKline (Inst); Lilly (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from invention (I)
Expert Testimony - Elmhurst Hospital; NYU School of Medicine
 
Payal Shah
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Johnson & Johnson (I); Lilly; Merck (I); Moderna Therapeutics; Novartis (I); Novo Nordisk; Novo Nordisk (I); Pfizer (I)
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Daiichi Sankyo; Gilead Sciences
Research Funding - AstraZeneca (Inst); Zenith Epigenetics (Inst)
 
Matthew Morrow
Employment - Inovio Pharmaceuticals
Stock and Other Ownership Interests - Inovio Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Inovio Pharmaceuticals
 
Jeffrey Skolnik
Employment - Inovio Pharmaceuticals
Stock and Other Ownership Interests - Inovio Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Inovio Pharmaceuticals
 
Robert Vonderheide
Consulting or Advisory Role - BMS; EMD Serono Research & Development Institute; Grey Wolf Therapeutics
Research Funding - Revolution Medicines
Patents, Royalties, Other Intellectual Property - Inventor on a licensed patient regarding cancer vaccine antigens; Inventor on patent regarding Kras immune epitopes; Receives royalties from Children’s Hospital Boston for a licensed research-only monoclonal antibody